Development of novel vaccines against human cytomegalovirus

Congenital human cytomegalovirus (HCMV) infection and HCMV infection of the immunosuppressed patients cause significant morbidity and mortality, and vaccine development against HCMV is a major public health priority. Efforts to develop HCMV vaccines have been ongoing for 50 y, though no HCMV vaccine...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Xinle, Snapper, Clifford M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930071/
https://www.ncbi.nlm.nih.gov/pubmed/31017831
http://dx.doi.org/10.1080/21645515.2019.1593729

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930071/
https://www.ncbi.nlm.nih.gov/pubmed/31017831
http://dx.doi.org/10.1080/21645515.2019.1593729

Ejemplares similares